Clinical Trial Update: A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study comparing subcutaneous teprotumumab with placebo in adults with moderate-to-severe active Thyroid Eye Disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Teprotumumab (teprotumumab)

Snippet

Sponsor: Amgen | Conditions: Thyroid Eye Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING